Real-time enrollment status for this acute myeloid leukaemia (aml) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:43 AM UTC
| NCT Number | NCT07154823 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukaemia (AML) |
| Phase | Clinical Trial |
| Target Enrollment | 550 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Tempus AI |
| Last Updated on CT.gov | June 15, 2026 (4 weeks ago) |
As of July 13, 2026: Clinical trial NCT07154823 is currently recruiting participants. This clinical trial study for acute myeloid leukaemia (aml) is actively seeking new participants at 6 locations across the United States. The study is sponsored by Tempus AI. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07154823 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07154823 was last updated 4 weeks ago (June 15, 2026). HelloStudys verifies this status automatically.